Skip to product information
1 of 1

A professionally designed brochure outlining the Blueprint for Australian Medicines Access Biosimilar Policy. The publication presents policy recommendations, supporting evidence, and strategic insights to promote the sustainable adoption of biosimilar medicines, improve patient access, and support the long-term sustainability of Australia's healthcare system.

Blueprint for Australian Medicines Access Biosimilar Policy - MRL-1009-AU

Blueprint for Australian Medicines Access Biosimilar Policy - MRL-1009-AU

Regular price $14.84 AUD + GST(each)
Regular price + GST(each) Sale price $14.84 AUD + GST(each)
Sale Sold out
Minimum Purchase 25
View full details